Merck Financial Statements From 2010 to 2026

MRK Stock   27.83  0.87  3.23%   
Merck CDR's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Merck CDR's valuation are provided below:
Market Capitalization
264.2 B
Enterprise Value Revenue
4.9109
We have found fourty-four available fundamental ratios for Merck CDR, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Merck CDR's last-minute fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Merck CDR Total Revenue

68.36 Billion

Check Merck CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck CDR's main balance sheet or income statement drivers, such as Tax Provision of 2.5 B, Interest Income of 1 B or Selling General Administrative of 11.5 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck CDR Valuation or Volatility modules.
  
This module can also supplement various Merck CDR Technical models . Check out the analysis of Merck CDR Correlation against competitors.

Merck CDR Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets122.1 B134.7 B111.7 B
Slightly volatile
Total Current Liabilities28.7 B32.7 B25.3 B
Slightly volatile
Total Stockholder Equity47.6 B53.3 B46 B
Pretty Stable
Retained Earnings65.3 B72.5 B61.7 B
Slightly volatile
Other Assets10.9 B15.6 B8.1 B
Slightly volatile
Long Term Debt35.5 B39.6 B30.4 B
Slightly volatile
Cash And Short Term Investments12.5 B15.7 B13 B
Pretty Stable
Net Receivables11 B11.8 B9.8 B
Slightly volatile
Good Will23.5 B24.9 B21.6 B
Slightly volatile
Common Stock Shares OutstandingB2.3 B2.5 B
Slightly volatile
Short Term Investments319.2 M402.3 M464.4 M
Slightly volatile
Long Term Debt Total35.5 B39.6 B30.4 B
Slightly volatile
Liabilities And Stockholders Equity122.1 B134.7 B111.7 B
Slightly volatile
Capital Surpluse49 B51.4 B45.1 B
Slightly volatile
Inventory6.7 BB6.1 B
Slightly volatile
Other Current Assets8.1 BB6.9 B
Slightly volatile
Total Liabilities74.5 B81.4 B65.7 B
Slightly volatile
Total Current Assets39.1 B44.6 B36.4 B
Slightly volatile
Cash And Equivalents12 B15.2 B12.5 B
Pretty Stable
Intangible Assets14.6 B14.7 B19.2 B
Slightly volatile
Common Stock1.4 B1.6 B1.8 B
Slightly volatile
Property Plant Equipment26.5 B28.9 B23.6 B
Slightly volatile

Merck CDR Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision2.5 B2.8 BB
Slightly volatile
Interest IncomeB663 M2.1 B
Slightly volatile
Selling General Administrative11.5 B10.6 B10.1 B
Slightly volatile
Total Revenue68.4 B65 B60.5 B
Slightly volatile
Gross Profit51.9 B53 B43.9 B
Slightly volatile
Operating Income16.7 B21.2 B17.2 B
Pretty Stable
Cost Of Revenue12 B12 B16.4 B
Slightly volatile
Total Operating Expenses37.5 B43.8 B42.4 B
Pretty Stable
Income Before Tax16.3 B21.1 B16.1 B
Very volatile
Net Income Applicable To Common Shares13.8 B18.3 B14 B
Pretty Stable
Net Income13.8 B18.3 B14 B
Pretty Stable

Merck CDR Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation2.1 B2.4 B1.9 B
Slightly volatile
Dividends Paid8.2 BB7.3 B
Slightly volatile
Capital Expenditures3.1 BB4.1 B
Slightly volatile
Total Cash From Operating Activities19.6 B24.7 B19.2 B
Pretty Stable
Net Income11.7 B19.7 B14 B
Pretty Stable

Merck Fundamental Market Drivers

Forward Price Earnings24.2131
Cash And Short Term Investments13.7 B

About Merck CDR Financial Statements

Merck CDR investors utilize fundamental indicators, such as revenue or net income, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue65 B68.4 B
Cost Of Revenue12 B12 B

Pair Trading with Merck CDR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Merck CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck CDR will appreciate offsetting losses from the drop in the long position's value.

Moving together with Merck Stock

  0.89JNJ Johnson Johnson CDRPairCorr
  1.0MRK MerckPairCorr
  0.84AMGN Amgen CDRPairCorr

Moving against Merck Stock

  0.53VRY Petro Victory EnergyPairCorr
  0.37HWO High Arctic EnergyPairCorr
The ability to find closely correlated positions to Merck CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck CDR to buy it.
The correlation of Merck CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Merck CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Merck Stock

Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.